If evaluated in the first trimester as a single biomarker PP13 provided 83% detection rate for 10% false positive rate for early preeclampsia (<34 weeks), 66% for preterm preeclampsia (<37 weeks), and 47% for all cases of preeclampsia [66]. Here, LGALS13 is linked to preeclampsia.